Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06914011
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
172
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
Tislelizumab
Sponsor
Asan Medical Center